14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $65.50 $83.89 Wednesday, 24th Apr 2024 AXSM stock ended at $71.17. This is 2.61% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 4.61% from a day low at $69.92 to a day high of $73.14.
90 days $65.50 $98.40
52 weeks $55.03 $98.40

Historical Axsome Therapeutics prices

Date Open High Low Close Volume
Jul 13, 2021 $64.71 $65.44 $63.24 $63.42 180 477
Jul 12, 2021 $65.28 $65.43 $63.88 $65.24 185 457
Jul 09, 2021 $65.10 $66.13 $64.21 $65.32 141 101
Jul 08, 2021 $61.81 $66.00 $61.55 $64.81 259 531
Jul 07, 2021 $65.00 $65.54 $62.70 $63.47 259 866
Jul 06, 2021 $65.71 $66.26 $63.71 $65.42 260 471
Jul 02, 2021 $67.94 $68.40 $66.00 $66.04 255 621
Jul 01, 2021 $66.80 $68.74 $66.50 $68.26 373 465
Jun 30, 2021 $68.81 $70.63 $66.96 $67.46 393 340
Jun 29, 2021 $71.40 $71.50 $69.30 $69.66 329 472
Jun 28, 2021 $73.50 $74.10 $71.28 $72.46 385 239
Jun 25, 2021 $70.15 $73.74 $69.25 $73.50 665 566
Jun 24, 2021 $69.63 $71.32 $69.40 $70.51 289 456
Jun 23, 2021 $71.77 $72.49 $69.32 $69.68 277 549
Jun 22, 2021 $70.77 $71.69 $70.24 $71.16 325 478
Jun 21, 2021 $66.93 $70.97 $65.85 $70.75 395 189
Jun 18, 2021 $66.30 $67.69 $65.20 $67.35 477 434
Jun 17, 2021 $65.07 $66.61 $64.80 $66.54 193 465
Jun 16, 2021 $67.30 $68.01 $63.61 $65.62 404 154
Jun 15, 2021 $69.50 $69.56 $66.14 $67.21 402 535
Jun 14, 2021 $66.39 $68.50 $66.39 $67.52 265 492
Jun 11, 2021 $67.97 $67.97 $65.78 $66.39 261 642
Jun 10, 2021 $64.48 $69.29 $63.95 $67.57 466 904
Jun 09, 2021 $65.09 $66.00 $63.13 $63.50 271 545
Jun 08, 2021 $66.00 $66.39 $63.50 $65.40 265 112
Click to get the best stock tips daily for free!

About Axsome Therapeutics

Axsome Therapeutics Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial ... AXSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT